BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toh TB, Lim JJ, Chow EK. Epigenetics of hepatocellular carcinoma. Clin Transl Med. 2019;8:13. [PMID: 31056726 DOI: 10.1186/s40169-019-0230-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Stephens Z, O'Brien D, Dehankar M, Roberts LR, Iyer RK, Kocher JP. Exogene: A performant workflow for detecting viral integrations from paired-end next-generation sequencing data. PLoS One 2021;16:e0250915. [PMID: 34550971 DOI: 10.1371/journal.pone.0250915] [Reference Citation Analysis]
2 Elsewify WAE, Hassan EA, Mekky MA, Abd El-Rehim ASE, Sayed ZEA, Abdel Malek MO, ElMelegy TTH, Sabry A. Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels. Int J Gen Med 2020;13:147-55. [PMID: 32431531 DOI: 10.2147/IJGM.S249272] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Goto K, Roca Suarez AA, Wrensch F, Baumert TF, Lupberger J. Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip. Int J Mol Sci. 2020;21. [PMID: 32357520 DOI: 10.3390/ijms21093057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
4 Zhang X, Wang L, Li N, Xiao Y. Assessing chromatin condensation for epigenetics with a DNA-targeting sensor by FRET and FLIM techniques. Chinese Chemical Letters 2021;32:2395-9. [DOI: 10.1016/j.cclet.2021.02.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhao J, Li H, Zhao S, Wang E, Zhu J, Feng D, Zhu Y, Dou W, Fan Q, Hu J, Jia L, Liu L. Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling. Mol Cancer 2021;20:46. [PMID: 33658044 DOI: 10.1186/s12943-021-01343-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Huang P, Xu M, Han H, Zhao X, Li MD, Yang Z. Integrative Analysis of Epigenome and Transcriptome Data Reveals Aberrantly Methylated Promoters and Enhancers in Hepatocellular Carcinoma. Front Oncol 2021;11:769390. [PMID: 34858848 DOI: 10.3389/fonc.2021.769390] [Reference Citation Analysis]
7 Abbaszadeh S, Rashidipour M, Khosravi P, Shahryarhesami S, Ashrafi B, Kaviani M, Moradi Sarabi M. Biocompatibility, Cytotoxicity, Antimicrobial and Epigenetic Effects of Novel Chitosan-Based Quercetin Nanohydrogel in Human Cancer Cells. Int J Nanomedicine 2020;15:5963-75. [PMID: 32884259 DOI: 10.2147/IJN.S263013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Davenport CF, Scheithauer T, Dunst A, Bahr FS, Dorda M, Wiehlmann L, Tran DDH. Genome-Wide Methylation Mapping Using Nanopore Sequencing Technology Identifies Novel Tumor Suppressor Genes in Hepatocellular Carcinoma. Int J Mol Sci 2021;22:3937. [PMID: 33920410 DOI: 10.3390/ijms22083937] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Dal Bo M, De Mattia E, Baboci L, Mezzalira S, Cecchin E, Assaraf YG, Toffoli G. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma. Drug Resistance Updates 2020;51:100702. [DOI: 10.1016/j.drup.2020.100702] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
10 Elpek GO. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update. World J Clin Cases 2021; 9(19): 4890-4917 [PMID: 34307543 DOI: 10.12998/wjcc.v9.i19.4890] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang F, Malnassy G, Qiu W. The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma. Front Oncol 2021;11:653037. [PMID: 33791228 DOI: 10.3389/fonc.2021.653037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Ruan C, You L, Qiu Y, Cui X, Wu D. Tubeimoside I induces autophagy in HepG2 cells by activating the AMP-activated protein kinase signaling pathway. Oncol Lett 2020;20:623-30. [PMID: 32537027 DOI: 10.3892/ol.2020.11604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Karakülah G, Yandim C. Identification of differentially expressed genomic repeats in primary hepatocellular carcinoma and their potential links to biological processes and survival. Turk J Biol 2021;45:599-612. [PMID: 34803457 DOI: 10.3906/biy-2104-13] [Reference Citation Analysis]
14 Kim SY, Hwang S, Lee BR, Hong JA, Sung YH, Kim I. Inhibition of histone demethylase KDM4 by ML324 induces apoptosis through the unfolded protein response and Bim upregulation in hepatocellular carcinoma cells. Chem Biol Interact 2022;353:109806. [PMID: 34999051 DOI: 10.1016/j.cbi.2022.109806] [Reference Citation Analysis]
15 El Khoury D, Fayjaloun S, Nassar M, Sahakian J, Aad PY. Updates on the Effect of Mycotoxins on Male Reproductive Efficiency in Mammals. Toxins (Basel) 2019;11:E515. [PMID: 31484408 DOI: 10.3390/toxins11090515] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
16 Gougelet A. Epigenetic modulation of immunity: towards new therapeutic avenues in hepatocellular carcinoma? Gut 2019;68:1727-8. [PMID: 31243054 DOI: 10.1136/gutjnl-2019-319084] [Reference Citation Analysis]
17 Wang X, Cheng Y, Yan LL, An R, Wang XY, Wang HY. Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma. Onco Targets Ther 2020;13:9901-16. [PMID: 33116575 DOI: 10.2147/OTT.S267812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Varghese RS, Barefoot ME, Jain S, Chen Y, Zhang Y, Alley A, Kroemer AH, Tadesse MG, Kumar D, Sherif ZA, Ressom HW. Integrative Analysis of DNA Methylation and microRNA Expression Reveals Mechanisms of Racial Heterogeneity in Hepatocellular Carcinoma. Front Genet 2021;12:708326. [PMID: 34557219 DOI: 10.3389/fgene.2021.708326] [Reference Citation Analysis]
19 Shokoohian B, Negahdari B, Aboulkheyr Es H, Abedi-Valugerdi M, Baghaei K, Agarwal T, Maiti TK, Hassan M, Najimi M, Vosough M. Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights. J Cell Mol Med 2021;25:8602-14. [PMID: 34423899 DOI: 10.1111/jcmm.16875] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Koufaris C, Kirmizis A. Identification of NAA40 as a Potential Prognostic Marker for Aggressive Liver Cancer Subtypes. Front Oncol 2021;11:691950. [PMID: 34150665 DOI: 10.3389/fonc.2021.691950] [Reference Citation Analysis]
21 Ghafouri-Fard S, Gholipour M, Hussen BM, Taheri M. The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma. Front Oncol 2021;11:649107. [PMID: 33968749 DOI: 10.3389/fonc.2021.649107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
22 Liu Q, Lu F, Chen Z. Identification of MT1E as a novel tumor suppressor in hepatocellular carcinoma. Pathol Res Pract 2020;216:153213. [PMID: 32956919 DOI: 10.1016/j.prp.2020.153213] [Reference Citation Analysis]
23 Luo QK, Zhang H, Li L. Research Advances on DNA Methylation in Idiopathic Pulmonary Fibrosis. Adv Exp Med Biol 2020;1255:73-81. [PMID: 32949391 DOI: 10.1007/978-981-15-4494-1_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Nagaraju GP, Dariya B, Kasa P, Peela S, El-Rayes BF. Epigenetics in hepatocellular carcinoma. Semin Cancer Biol 2021:S1044-579X(21)00211-X. [PMID: 34324953 DOI: 10.1016/j.semcancer.2021.07.017] [Reference Citation Analysis]
25 Liu Y, Gao H, Wang X, Zeng Y. Methylation of Inflammatory Cells in Lung Diseases. Adv Exp Med Biol 2020;1255:63-72. [PMID: 32949390 DOI: 10.1007/978-981-15-4494-1_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Chuang KT, Wang SN, Hsu SH, Wang LT. Impact of bromodomain-containing protein 4 (BRD4) and intestine-specific homeobox (ISX) expression on the prognosis of patients with hepatocellular carcinoma' for better clarity. Cancer Med 2021;10:5545-56. [PMID: 34173348 DOI: 10.1002/cam4.4094] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Niu J, Li W, Liang C, Wang X, Yao X, Yang R, Zhang Z, Liu H, Liu F, Pei S, Li W, Sun H, Fang D, Xie S. EGF promotes DKK1 transcription in hepatocellular carcinoma by enhancing the phosphorylation and acetylation of histone H3. Sci Signal 2020;13. [DOI: 10.1126/scisignal.abb5727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Meng Z, Wu J, Liu X, Zhou W, Ni M, Liu S, Guo S, Jia S, Zhang J. Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis. J Int Med Res 2020;48:300060520910019. [PMID: 32722976 DOI: 10.1177/0300060520910019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
29 Xiang H, Luo M, Hou P, Xiao Z, Huang Z, Feng Q, Zhang R, Li Y, Wu L. miR-124-3p combined with miR-506-3p delay hepatic carcinogenesis via modulating sirtuin 1. Biomarkers 2021;26:196-206. [PMID: 33401967 DOI: 10.1080/1354750X.2020.1854856] [Reference Citation Analysis]
30 Tapadar S, Fathi S, Wu B, Sun CQ, Raji I, Moore SG, Arnold RS, Gaul DA, Petros JA, Oyelere AK. Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents. Cancers (Basel) 2020;12:E3095. [PMID: 33114147 DOI: 10.3390/cancers12113095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Fernández-Barrena MG, Arechederra M, Colyn L, Berasain C, Avila MA. Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg. JHEP Rep 2020;2:100167. [PMID: 33134907 DOI: 10.1016/j.jhepr.2020.100167] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
32 Zhang H, Spencer K, Burley SK, Zheng XFS. Toward improving androgen receptor-targeted therapies in male-dominant hepatocellular carcinoma. Drug Discov Today 2021;26:1539-46. [PMID: 33561464 DOI: 10.1016/j.drudis.2021.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Reddy D, Bhattacharya S, Shah S, Rashid M, Gupta S. DNA methylation mediated downregulation of histone H3 variant H3.3 affects cell proliferation contributing to the development of HCC. Biochim Biophys Acta Mol Basis Dis 2022;1868:166284. [PMID: 34626773 DOI: 10.1016/j.bbadis.2021.166284] [Reference Citation Analysis]
34 Cabral LKD, Reyes PAC, Crocè LS, Tiribelli C, Sukowati CHC. The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma. Diagnostics (Basel) 2021;11:1825. [PMID: 34679523 DOI: 10.3390/diagnostics11101825] [Reference Citation Analysis]
35 Zeisel MB, Guerrieri F, Levrero M. Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma. J Clin Med 2021;10:1715. [PMID: 33923385 DOI: 10.3390/jcm10081715] [Reference Citation Analysis]
36 Liu X, Zhang T, Li Y, Zhang Y, Zhang H, Wang X, Li L. The Role of Methylation in the CpG Island of the ARHI Promoter Region in Cancers. Adv Exp Med Biol. 2020;1255:123-132. [PMID: 32949395 DOI: 10.1007/978-981-15-4494-1_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Kong W, Li X, Xu H, Gao Y. Development and validation of a m6A-related gene signature for predicting the prognosis of hepatocellular carcinoma. Biomark Med 2020;14:1217-28. [PMID: 33021385 DOI: 10.2217/bmm-2020-0178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Farzaneh Z, Vosough M, Agarwal T, Farzaneh M. Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches. Cancer Cell Int 2021;21:208. [PMID: 33849569 DOI: 10.1186/s12935-021-01924-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Dulman RS, Wandling GM, Pandey SC. Epigenetic mechanisms underlying pathobiology of alcohol use disorder. Curr Pathobiol Rep 2020;8:61-73. [PMID: 33747641 DOI: 10.1007/s40139-020-00210-0] [Reference Citation Analysis]
40 Yuan LT, Lee WJ, Yang YC, Chen BR, Yang CY, Chen MW, Chen JQ, Hsiao M, Chien MH, Hua KT. Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122. Cancers (Basel) 2021;13:2376. [PMID: 34069116 DOI: 10.3390/cancers13102376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Li Y, Zhang T, Zhang H, Wang X, Liu X, Huang Q, Li L. Clinical Significance of P16 Gene Methylation in Lung Cancer. Adv Exp Med Biol 2020;1255:133-42. [PMID: 32949396 DOI: 10.1007/978-981-15-4494-1_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Lee NH, Kim SJ, Hyun J. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer. Biomedicines 2021;9:347. [PMID: 33808155 DOI: 10.3390/biomedicines9040347] [Reference Citation Analysis]
43 Rajan PK, Udoh UA, Sanabria JD, Banerjee M, Smith G, Schade MS, Sanabria J, Sodhi K, Pierre S, Xie Z, Shapiro JI, Sanabria J. The Role of Histone Acetylation-/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E8894. [PMID: 33255318 DOI: 10.3390/ijms21238894] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
44 Afzal M, Kazmi I, Alharbi KS, Quazi AM, Nadeem MS, Alotaibi NH, Ameeduzzafar, Alruwaili NK, Anwar F, Alenezi SK, Al-Sanea MM. Genotoxic potential of a novel PDE-4B inhibitor Apremilast by chromosomal aberration and micronucleus assay in mice. Saudi Pharm J 2020;28:615-20. [PMID: 32435143 DOI: 10.1016/j.jsps.2020.03.014] [Reference Citation Analysis]